Skip Navigation



JAC Advance Access published online on December 1, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh517
© 2004 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
55/1/119    most recent
dkh517v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sompolinsky, D.
Right arrow Articles by Katcoff, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sompolinsky, D.
Right arrow Articles by Katcoff, D. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received September 12, 2004
Revised October 21, 2004
Accepted October 28, 2004

Brief report

Integron-mediated ESBL resistance in rare serotypes of Escherichia coli causing infections in an elderly population of Israel

David Sompolinsky 1 *, Yeshayahu Nitzan 2 *, Shaul Tetry 1, Moshe Wolk 3, Israel Vulikh 4, Mette Barendorff Kerrn 5, Dorthe Sandvang 5, Gitit Hershkovits 2 *, and Don J. Katcoff 2* *

1 Faculty of Life Sciences, Bar Ilan University, Ramat Gan 52900, Israel; Microbiology Laboratory, Ma'aynei-Hayeshua Hospital, Bnei Brak, Israel
2 Faculty of Life Sciences, Bar Ilan University, Ramat Gan 52900, Israel
3 Ministry of Health Central Laboratories, Jerusalem, Israel
4 Microbiology Laboratory, Ma'aynei-Hayeshua Hospital, Bnei Brak, Israel
5 Division of Microbiology, Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark

* To whom correspondence should be addressed.
Don J. Katcoff, E-mail: katcoff{at}mail.biu.ac.il


  Abstract

Objectives: To identify and characterize the aetiology of an outbreak of extra-intestinal multidrug-resistant Escherichia coli infections in elderly patients in Israel.

Methods: Extended-spectrum {beta}-lactamase (ESBL)-producing clinical isolates of E. coli from extra-intestinal sources were tested for susceptibility to non-{beta}-lactam drugs, and their serotypes were determined. Restriction enzyme digestion, followed by PFGE of DNA purified from isolates, was used to classify the phylogenetic relationship between them. Plasmid DNA from five isolates of different serotypes was used to transform an E. coli laboratory strain. The plasmids were partially sequenced.

Results: E. coli isolates from 86 patients, mostly elderly, were shown to be positive for inhibitor-susceptible ESBLs, and more resistant to cefotaxime than to ceftazidime. Ninety-six per cent of ESBL producers were also resistant to gentamicin, and 100% to trimethoprim/sulfamethoxazole and ciprofloxacin. All isolates belonged to one of five serotypes. PFGE analysis of purified DNA yielded 17 profiles. Sequencing of plasmids isolated from the transformants identified sul1, aac(6')-Ib and blaCTX-M-2. These genes were embedded in an integron, InS21.

Conclusions: Extra-intestinal infections with ESBL-producing E. coli of different serotypes and probably mixed clonality showed a surprising homogeneity in resistance profiles, with 100% being co-resistant to ciprofloxacin and trimethoprim/sulfamethoxazole, and 96% to gentamicin. Plasmid DNA from three isolates from different serotypes contained integron InS21, previously demonstrated in Salmonella enterica from Argentina. This is the first molecular identification of an ESBL gene and integron in Israel or neighbouring geographical areas.

Keywords: extended-spectrum {beta}-lactamases; Enterobacteriaceae; E. coli.

*Contributed equally to this publication.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
G. Ll. Jones, R. E. Warren, S. J. Skidmore, V. A. Davies, T. Gibreel, and M. Upton
Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum {beta}-lactamases
J. Antimicrob. Chemother., December 1, 2008; 62(6): 1245 - 1251.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.